It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The early detection and accurate histopathological diagnosis of gastric cancer increase the chances of successful treatment. The worldwide shortage of pathologists offers a unique opportunity for the use of artificial intelligence assistance systems to alleviate the workload and increase diagnostic accuracy. Here, we report a clinically applicable system developed at the Chinese PLA General Hospital, China, using a deep convolutional neural network trained with 2,123 pixel-level annotated H&E-stained whole slide images. The model achieves a sensitivity near 100% and an average specificity of 80.6% on a real-world test dataset with 3,212 whole slide images digitalized by three scanners. We show that the system could aid pathologists in improving diagnostic accuracy and preventing misdiagnoses. Moreover, we demonstrate that our system performs robustly with 1,582 whole slide images from two other medical centres. Our study suggests the feasibility and benefits of using histopathological artificial intelligence assistance systems in routine practice scenarios.
The early detection and accurate histopathological diagnosis of gastric cancer are essential factors that can help increase the chances of successful treatment. Here, the authors report on a digital pathology tool achieving high performance on a real world test dataset and show that the system can aid pathologists in improving diagnostic accuracy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 The Chinese PLA General Hospital, Department of Pathology, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894)
2 Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
3 Peking Union Medical College Hospital, Department of Pathology, Beijing, China (GRID:grid.413106.1) (ISNI:0000 0000 9889 6335)
4 Beijing Shijitan Hospital, Capital Medical University, Department of Pathology, Beijing, China (GRID:grid.414367.3)
5 Thorough Images, Beijing, China (GRID:grid.414367.3)
6 Peking University Health Science Center, Department of Pathology, Third Hospital, School of Basic Medical Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
7 Thorough Images, Beijing, China (GRID:grid.11135.37); Tsinghua University, Institute for Interdisciplinary Information Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
8 Tsinghua University, Institute for Interdisciplinary Information Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
9 Duke University Medical Center, Department of Pathology, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216)